Torray Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.39M | Buy |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $1.41M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Buy |
|
|||||
|
2023
Q2 | $952K | Buy |
|
|||||
|
2023
Q1 | $1.06M | Buy |
|
|||||
|
2022
Q4 | $1.12M | Sell |
|
|||||
|
2022
Q3 | $958K | Sell |
|
|||||
|
2022
Q2 | $959K | Sell |
|
|||||
|
2022
Q1 | $893K | Sell |
|
|||||
|
2021
Q4 | $1.08M | Sell |
|
|||||
|
2021
Q3 | $1.27M | Buy |
|
|||||
|
2021
Q2 | $1.35M | Buy |
|
|||||
|
2021
Q1 | $1.21M | Sell |
|
|||||
|
2020
Q4 | $5.8M | Sell |
|
|||||
|
2020
Q3 | $5.2M | Buy |
|
|||||
|
2020
Q2 | $6.67M | Sell |
|
|||||
|
2020
Q1 | $5.12M | Buy |
|
|||||
|
2019
Q4 | $4.78M | Sell |
|
|||||
|
2019
Q3 | $13.6M | Buy |
|
|||||
|
2019
Q2 | $17.2M | Sell |
|
|||||
|
2019
Q1 | $19.6M | Sell |
|
|||||
|
2018
Q4 | $19.1M | Sell |
|
|||||
|
2018
Q3 | $23M | Sell |
|
|||||
|
2018
Q2 | $22.8M | Sell |
|
|||||
|
2018
Q1 | $20.3M | Buy |
|
|||||
|
2017
Q4 | $22.1M | Buy |
|
|||||
|
2017
Q3 | $21.3M | Buy |
|
|||||
|
2017
Q2 | $20.6M | Sell |
|
|||||
|
2017
Q1 | $21.6M | Sell |
|
|||||
|
2016
Q4 | $20.7M | Buy |
|
|||||
|
2016
Q3 | $18M | Sell |
|
|||||
|
2016
Q2 | $28.3M | Sell |
|
|||||
|
2016
Q1 | $37M | Buy |
|
|||||
|
2015
Q4 | $24.1M | Buy |
|
|||||
|
2015
Q3 | $24M | Sell |
|
|||||
|
2015
Q2 | $31.5M | Sell |
|
|||||
|
2015
Q1 | $32M | Sell |
|
|||||
|
2014
Q4 | $27.5M | Sell |
|
|||||
|
2014
Q3 | $25.3M | Buy |
|
|||||
|
2014
Q2 | $17.1M | Buy |
|
|||||
|
2014
Q1 | $4.42M | Buy |
|